Willner & Heller’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
469
+74
| +19% | +$38.9K | 0.21% | 135 |
|
|
2025
Q1 | $250K | Sell |
395
-4
| -1% | -$2.53K | 0.23% | 129 |
|
|
2024
Q4 | $284K | Buy |
399
+15
| +4% | +$10.7K | 0.25% | 122 |
|
|
2024
Q3 | $404K | Hold |
384
| – | – | 0.36% | 96 |
|
|
2024
Q2 | $404K | Hold |
384
| – | – | 0.39% | 87 |
|
|
2024
Q1 | $370K | Buy |
384
+5
| +1% | +$4.81K | 0.37% | 94 |
|
|
2023
Q4 | $333K | Buy |
+379
| New | +$333K | 0.37% | 94 |
|
|
2022
Q4 | $273K | Sell |
379
-7
| -2% | -$5.05K | 0.39% | 98 |
|
|
2022
Q3 | $266K | Hold |
386
| – | – | 0.43% | 90 |
|
|
2022
Q2 | $228K | Hold |
386
| – | – | 0.35% | 110 |
|
|
2022
Q1 | $244K | Hold |
386
| – | – | 0.3% | 120 |
|
|
2021
Q4 | $234K | Buy |
+386
| New | +$234K | 0.31% | 122 |
|